AbbVie's Humira gets a U.S. rival, but costs could stay high | WSAU News/Talk 550 AM · 99.9 FM
By Patrick Wingrove (Reuters) - U.S. patients will finally get access to cheaper versions of AbbVie Inc's blockbuster arthritis drug Humira this year,...